These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 19560882

  • 21. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
    Krstevska V, Tolevska C, Zafirova-Ivanova B, Stojkovski I, Crvenkova S.
    J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
    [Abstract] [Full Text] [Related]

  • 22. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
    Porceddu SV, Campbell B, Rischin D, Corry J, Weih L, Guerrieri M, Grossi M, Peters LJ.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):365-73. PubMed ID: 15380568
    [Abstract] [Full Text] [Related]

  • 23. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
    Schiefke F, Hildebrandt G, Pohlmann S, Heinicke F, Hemprich A, Frerich B.
    J Craniomaxillofac Surg; 2008 Jul 01; 36(5):285-92. PubMed ID: 18353667
    [Abstract] [Full Text] [Related]

  • 24. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies.
    Grimard L, Esche B, Lamothe A, Cygler J, Spaans J.
    Head Neck; 2006 Oct 01; 28(10):888-95. PubMed ID: 16721742
    [Abstract] [Full Text] [Related]

  • 25. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, Brockstein BE, List MA, Portugal L, Pelzer H, Weichselbaum RR, Vokes EE.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [Abstract] [Full Text] [Related]

  • 26. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ, Sessions DG, Lenox J, Newland D, Simpson J, Haughey BH.
    Laryngoscope; 2004 Aug 01; 114(8):1438-46. PubMed ID: 15280724
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
    Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE.
    Head Neck; 2004 Jul 01; 26(7):561-72. PubMed ID: 15229898
    [Abstract] [Full Text] [Related]

  • 31. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 32. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
    Langendijk JA, Kasperts N, Leemans CR, Doornaert P, Slotman BJ.
    Radiother Oncol; 2006 Mar 01; 78(3):306-12. PubMed ID: 16524634
    [Abstract] [Full Text] [Related]

  • 33. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
    Harrison LB, Minsky BD, Enker WE, Mychalczak B, Guillem J, Paty PB, Anderson L, White C, Cohen AM.
    Int J Radiat Oncol Biol Phys; 1998 Sep 01; 42(2):325-30. PubMed ID: 9788411
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1440-50. PubMed ID: 15590175
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
    Pellizzon AC, dos Santos Novaes PE, Conte Maia MA, Ferrigno R, Fogarolli R, Salvajoli JV, Kowalski LP.
    Head Neck; 2005 Dec 01; 27(12):1035-41. PubMed ID: 16114005
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence.
    Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, Phillips TL, Fu KK, Eisele DW.
    Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):152-9. PubMed ID: 16904520
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.